Market Pulse
KIS quote snapshot · Sep 21, 2026 12:30 KST · KIS quote snapshots + ECOS · 30 min refresh
KOSPI
7,011.79
+117.56 (+1.71%)
KOSDAQ
835.45
+8.33 (+1.01%)
KOSPI 200
1,113.23
+23.00 (+2.11%)
USD/KRW
1,383.30
000100KOSPI·Feb 12, 2026
Focus on pace of lazertinib growth and out-licensing potential
Mirae Asset Securities published a company analysis report on YUHAN CORPORATION (000100) titled "Focus on pace of lazertinib growth and out-licensing potential".
Summary
Covers YUHAN CORPORATION (000100).
Covered stock
More on 000100
Lazcluze uptake likely to accelerate; growing out-licensing potentialMirae Asset Securities · Jul 31, 2026Initiating Coverage: Royalties Should Begin in EarnestKB Securities · May 27, 2026Excluding Base Effects, Results SolidKB Securities · Nov 06, 2025API exports and licensing income drive earnings surpriseMirae Asset Securities · Jul 31, 2025Earnings miss due to absence of milestone income, but API growth stands outMirae Asset Securities · May 12, 2025MARIPOSA OS data to be released in MarchMirae Asset Securities · Feb 24, 2025